FrancophonIA/ELRC3.0 huggingface dataset:
English: The symptoms can include fever, abdominal pain, malaise, back pain and increased inflammatory markers.
Croatian: Simptomi mogu uključivati vrućicu, bol u trbuhu, malaksalost, bol u leđima i povišene markere upale.
English: G-CSF can promote growth of myeloid cells in vitro and similar effects may be seen on some non-myeloid cells in vitro.
Croatian: G-CSF može potaknuti rast mijeloičnih stanica in vitro, a slični učinci mogu se vidjeti i kod nekih nemijeloičnih stanica in vitro.
English: The overall rate of febrile neutropenia was 9% of patients treated with pegfilgrastim and 18% of patients treated with filgrastim (difference 9%, 95% CI of -16.8%,-1.1%).
Croatian: Ukupna stopa febrilne neutropenije u bolesnika liječenih pegfilgrastimom iznosila je 9 %, a 18 % u bolesnika liječenih filgrastimom (razlika 9 %, 95 % CI od -16,8 %, -1,1%).
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TRAY LABEL
Croatian: PODATCI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP PODLOŽAK
English: Pack size: Each carton contains 1 pre-filled syringe with an automatic needle guard blistered in a plastic tray.
Croatian: Veličina pakiranja: jedna kutija sadrži 1 napunjenu štrcaljku s automatskim štitnikom za iglu zapakiranu u plastični podložak.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 6 mg of pegfilgrastim * in 0.6 ml solution for injection.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna napunjena štrcaljka sadrži 6 mg pegfilgrastima* u 0,6 ml otopine za injekciju.
English: Thrombocytopenia1 Leukocytosis1
Croatian: Trombocitopenija1 Leukocitoza1
English: For more information, see section 5.1 Excipient with known effect
Croatian: Za više informacija vidjeti dio 5.1.
English: The youngest age group (0-5 years) had a higher mean exposure to pegfilgrastim (AUC) (± Standard Deviation) (47.9 ± 22.5 μg·hr/ml) than older children aged 6-11 years and 12-21 years (22.0 ± 13.1 μg hr/ml and 29.3 ± 23.2 μg·hr/ml, respectively) (see section 5.1).
Croatian: Djeca u najmlađoj dobnoj skupini (0 - 5 godina) imala su veću srednju ekspoziciju pegfilgrastimu (AUC) (± standardno odstupanje) (47,9 ± 22,5 μg·hr/ml) u odnosu na stariju djecu u dobi od 6 - 11 godina, odnosno 12 - 21 godine (22,0 ± 13,1 μg·hr/ml te 29,3 ± 23,2 μg·hr/ml) (vidjeti dio 5.1).
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION UDENYCA 6 mg pegfilgrastim
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA UDENYCA 6 mg pegfilgrastim s.c.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SYRINGE LABEL
Croatian: PODATCI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE NALJEPNICA NA ŠTRCALJKI
English: Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product.
Croatian: Bolesnici s nasljednim poremećajem nepodnošenja fruktoze ne smiju primiti/ne smije im se dati ovaj lijek.
English: Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy, pegfilgrastim should be administered at least 24 hours after administration of cytotoxic chemotherapy.
Croatian: Zbog moguće osjetljivosti mijeolidnih stanica koje se brzo dijele na citotoksičnu kemoterapiju, pegfilgrastim treba primijeniti najmanje 24 sata nakon primjene citotoksične kemoterapije.
English: Hypersensitivity-type reactions, including skin rash, urticaria, angioedema, dyspnoea, erythaema, flushing, and hypotension occurred on initial or subsequent treatment with pegfilgrastim (uncommon).
Croatian: Reakcije preosjetljivosti, uključujući osip na koži, urtikariju, angioedem, dispneju, eritem, navale crvenila i hipotenziju, javljale su se tijekom prvog ili sljedećeg liječenja pegfilgrastimom (manje često).
English: • allergic-type reactions, including redness and flushing, skin rash, and raised areas of the skin that itch.
Croatian: • reakcije alergijskog tipa, uključujući crvenilo i navale crvenila, osip na koži, izdignuta područja kože koja svrbe
English: In a phase II (n = 37) multicentre, randomised, open-label study of paediatric sarcoma patients receiving 100 μg/kg pegfilgrastim following cycle 1 of vincristine, doxorubicin and cyclophosphamide (VAdriaC/IE) chemotherapy, a longer duration of severe neutropenia (neutrophils < 0.5 x 109) was observed in younger children aged 0-5 yrs (8.9 days) compared to older children aged 6-11 years and 12-21 years (6 days and 3.7 days, respectively) and adults.
Croatian: U fazi II (n = 37) multicentričnog, randomiziranog, otvorenog ispitivanja pedijatrijskih bolesnika sa sarkomom koji su primali 100 μg/kg pegfilgrastima nakon 1. ciklusa kemoterapije vinkristinom, doksorubicinom i ciklofosfamidom (VAdriaC/IE) uočeno je dulje trajanje teške neutropenije (neutrofili < 0,5 x 109) u mlađe djece u dobi od 0-5 godina (8,9 dana) u odnosu na stariju djecu u dobi 6-11 i 12-21 godine (6 odnosno 3,7 dana) te odrasle.
English: Permanently discontinue pegfilgrastim in patients with clinically significant hypersensitivity.
Croatian: Liječenje pegfilgrastimom mora se trajno prekinuti u bolesnika koji razviju klinički značajnu preosjetljivost.
English: Over the entire study, the rate of febrile neutropenia was 13% of pegfilgrastim-treated patients compared with 20% of filgrastim-treated patients (difference 7%, 95% CI of -19%, 5%).
Croatian: Tijekom cijelog ispitivanja stopa febrilne neutropenije u bolesnika liječenih pegfilgrastimom iznosila je 13 %, a 20 % u bolesnika liječenih filgrastimom (razlika 7%, 95 % CI od -19 %, 5 %).
English: This medicine contains less than 1 mmol (23 mg) sodium per 6 mg dose, that is to say essentially ‘sodium-free'.
Croatian: Ovaj lijek sadrži manje od 1 mmol (23 mg) natrija po dozi od 6 mg, odnosno zanemarive količine natrija.
English: Pre-filled syringe, with a coated bromobutyl rubber stopper and a stainless steel needle with automatic needle guard.
Croatian: Napunjena štrcaljka s obloženim gumenim čepom od bromobutila i iglom od nehrđajućeg čelika s automatskim štitnikom za iglu.
English: Pegfilgrastim contains less than 1 mmol (23 mg) sodium per 6 mg dose, that is to say, essentially 'sodium-free'.
Croatian: Pegfilgrastim sadrži manje od 1 mmol natrija (23 mg) po dozi od 6 mg, odnosno sadrži zanemarive količine natrija.
English: Additionally a higher incidence of febrile neutropenia was observed in younger children aged 0-5 yrs (75%) compared to older children aged 6-11 years and 12-21 years (70% and 33%, respectively) and adults (see sections 4.8 and 5.2).
Croatian: Dodatno je primijećena i veća incidencija febrilne neutropenije u mlađe djece u dobi od 0-5 godina (75 %) u usporedbi sa starijom djecom u dobi od 6-11 i 12-21 godine (70 % odnosno 33 %) odnosno odraslima (vidjeti dio 4.8 i 5.2).
English: Pegfilgrastim is injected subcutaneously.
Croatian: Pegfilgrastim se injicira supkutano.
English: A higher frequency of serious adverse reactions in younger children aged 0-5 years (92%) has been observed compared to older children aged 6-11 and 12-21 years respectively (80% and 67%) and adults.
Croatian: Primijećena je veća učestalost ozbiljnih nuspojava u mlađe djece, u dobi 0-5 godina (92 %) u odnosu na stariju djecu, u dobi 6-11 godina (80 %) i 12-21 godina (67 %), odnosno odrasle.
English: There is insufficient information on the excretion of pegfilgrastim/ metabolites in human milk, a risk to the newborns/infants cannot be excluded.
Croatian: Nema dovoljno podataka o izlučivanju pegfilgrastima/metabolita u majčino mlijeko u ljudi.
English: FIGURE 8
Croatian: SLIKA 8.
English: UDENYCA contains the active substance pegfilgrastim.
Croatian: UDENYCA sadrži djelatnu tvar pegfilgrastim.
English: What you need to know before you use UDENYCA Do not use UDENYCA - if you are allergic to pegfilgrastim, filgrastim, or any of the other ingredients of this medicine.
Croatian: Nemojte primjenjivati lijek UDENYCA - ako ste alergični na pegfilgrastim, filgrastim ili neki drugi sastojak ovog lijeka.
English: Bone pain Musculoskeletal pain (myalgia, arthralgia, pain in extremity, back pain,
Croatian: Bol u kostima Mišićno-koštana bol (mijalgija, artralgija, bol u udovima, bol u leđima, mišićnokoštana bol, bol u vratu)
English: Isolated cases of sickle cell crises have been reported in patients with sickle cell trait or sickle cell disease (uncommon in sickle cell patients) (see section 4.4).
Croatian: Izolirani slučajevi krize srpastih stanica prijavljeni su u bolesnika koji imaju nasljedno obilježje srpastih stanica ili bolest srpastih stanica (manje često u bolesnika s bolesti srpastih stanica) (vidjeti dio 4.4).
English: DO NOT shake the pre-filled syringe.
Croatian: NEMOJTE tresti napunjenu štrcaljku.
English: UDENYCA 6 mg solution for injection in pre-filled syringe pegfilgrastim
Croatian: UDENYCA 6 mg otopina za injekciju u napunjenoj štrcaljki pegfilgrastim
English: In a second study (n = 310), which used a weight-adjusted dose (100 μg/kg), the mean duration of grade 4 neutropenia for the pegfilgrastim group was 1.7 days, compared with 1.8 days in the filgrastim group (difference 0.03 days, 95% CI -0.36, 0.30).
Croatian: U drugom ispitivanju (n=310), u kojemu je primjenjivana doza prilagođena tjelesnoj težini (100 μg/kg), srednje trajanje neutropenije 4. stupnja u skupini liječenoj pegfilgrastimom iznosilo je 1,7 dana, u usporedbi s 1,8 dana u skupini liječenoj filgrastimom (razlika 0,03 dana, 95 % CI -0,36, 0,30).
English: The syringes are provided with an automatic needle guard.
Croatian: Štrcaljka sadrži automatski štitnik za iglu.
English: • Store the pre-filled syringe in its original carton to protect from light until you are ready to use it.
Croatian: • Napunjenu štrcaljku čuvajte u originalnom pakiranju do primjene radi zaštite od svjetlosti.
English: Cases of capillary leak syndrome have been reported in the post marketing setting with G-CSF use.
Croatian: Slučajevi sindroma povećane propusnosti kapilara uz primjenu G-CSF-a prijavljeni su nakon stavljanja lijeka na tržište.
English: FIGURE 5
Croatian: SLIKA 5.
English: DO NOT recap the syringe.
Croatian: NEMOJTE ponovno vraćati kapicu na štrcaljku.
English: NAME OF THE MEDICINAL PRODUCT UDENYCA 6 mg solution for injection in pre-filled syringe
Croatian: NAZIV LIJEKA UDENYCA 6 mg otopina za injekciju u napunjenoj štrcaljki
English: In one study (n = 157), which used a 6 mg fixed dose of pegfilgrastim the mean duration of grade 4 neutropenia for the pegfilgrastim group was 1.8 days compared with 1.6 days in the filgrastim group (difference 0.23 days, 95% CI -0.15, 0.63).
Croatian: U jednom ispitivanju (n = 157), u kojemu je primjenjivana fiksna doza pegfilgrastima od 6 mg, srednje vrijeme trajanja neutropenije 4. stupnja u skupini koja je primala pegfilgrastim iznosilo je 1,8 dana, a 1,6 dana u skupini koja je primala filgrastim (razlika od 0,23 dana, 95 % CI -0,15, 0,63).
English: 10 Push plunger head down to deliver dose.
Croatian: Potisnite klip štrcaljke prema dolje da ubrizgate dozu.
English: FIGURE 16
Croatian: SLIKA 16.
English: How to store UDENYCA
Croatian: Kako čuvati lijek UDENYCA
English: About this pre-filled syringe with automatic needle guard
Croatian: O napunjenoj štrcaljki s automatskim štitnikom za iglu
English: Pegfilgrastim is a protein produced by biotechnology in bacteria called E. coli followed by conjugation with polyethylene glycol (PEG) It belongs to a group of proteins called cytokines.
Croatian: Pegfilgrastim je protein dobiven biotehnološkim postupkom u bakteriji E.coli, nakon čega slijedi konjugacija s polietilenglikolom (PEG).
English: • pain at the site of injection
Croatian: • bol na mjestu primjene injekcije
English: If you use more UDENYCA than you should If you use more UDENYCA than you should contact your doctor, pharmacist or nurse.
Croatian: Ako primijenite više lijeka UDENYCA nego što ste trebali, obratite se liječniku, ljekarniku ili medicinskoj sestri.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each pre-filled syringe contains 6 mg of pegfilgrastim in 0.6 ml solution.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna napunjena štrcaljka sadrži 6 mg pegfilgrastima u 0,6 ml otopine.
English: Acute Respiratory Distress Syndrome2; Pulmonary adverse reactions (interstitial pneumonia, pulmonary oedema, pulmonary infiltrates and pulmonary fibrosis)
Croatian: Plućne nuspojave (intersticijska upala pluća, plućni edem, plućni infiltrati i plućna fibroza);
English: Unless your doctor directs you otherwise, you must stop breast-feeding if you use UDENYCA.
Croatian: Ako primjenjujete lijek UDENYCA, morate prekinuti s dojenjem, osim ako Vaš liječnik ne savjetuje drugačije.
English: Solution for injection in pre-filled syringe (0.6 ml).
Croatian: OBLIK I SADRŽAJ Otopina za injekciju u napunjenoj štrcaljki (0,6 ml).
English: DO NOT use if the expiry date has passed.
Croatian: NEMOJTE upotrebljavati lijek ako je istekao rok valjanosti.
English: 1 single-use pre-filled syringe with automatic needle guard.
Croatian: 1 napunjena štrcaljka za jednokratnu primjenu s automatskim štitnikom za iglu.
English: - The other ingredients are acetic acid and sodium acetate (for pH adjustment), sorbitol (E420),
Croatian: - Pomoćne tvari su acetatna kiselina i natrijev acetat (za podešavanje pH vrijednosti), sorbitol
English: • redness at the site of injection
Croatian: • crvenilo na mjestu primjene injekcije
English: 6 Clean the injection site.
Croatian: Očistite mjesto primjene injekcije.
English: FIGURE 9
Croatian: SLIKA 9.
English: How to use UDENYCA
Croatian: Kako primjenjivati lijek UDENYCA
English: FIGURE 7
Croatian: SLIKA 7.
English: DO NOT use if the solution appears discoloured or cloudy.
Croatian: NEMOJTE upotrebljavati otopinu ako se čini bezbojna ili mutna.
English: SC
Croatian: ANC
English: (see Figure 8)
Croatian: • stražnjica (vidjeti Sliku 8.)
English: FIGURE 10
Croatian: SLIKA 10.
English: FIGURE 3
Croatian: SLIKA 3.
English: FIGURE 13
Croatian: SLIKA 13.
English: FIGURE 2
Croatian: SLIKA 2.
English: FIGURE 15
Croatian: SLIKA 15.
English: Transient elevations in LFT's for ALT or AST1
Croatian: Povišena razina laktatdehidrogenaze i alkalne fosfataze1; Prolazno povišenje vrijednosti testova jetrene funkcije za ALT ili AST1
English: Sodium acetate trihydrate (for pH adjustment) Acetic acid (for pH adjustment) Sorbitol (E420)
Croatian: 6.1 Popis pomoćnih tvari natrijev acetat trihidrat (za podešavanje pH vrijednosti) acetatna kiselina (za podešavanje pH vrijednosti) sorbitol (E420) polisorbat 20 voda za injekcije
English: • have any of the following or combination of the following side effects: - swelling or puffiness, which may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness These could be symptoms of condition called “Capillary Leak Syndrome” which causes blood to leak from the small blood vessels into your body.
Croatian: • ako imate znakove jedne od sljedećih ili kombinacije sljedećih nuspojava: oticanje ili podbuhlost, što može biti povezano s rjeđom učestalošću mokrenja, otežano disanje, oticanje trbuha i osjećaj punoće, te opći osjećaj umora.
English: FIGURE 14
Croatian: SLIKA 14.
English: FIGURE 11
Croatian: SLIKA 11.
English: 5 Select the injection site.
Croatian: Odaberite mjesto primjene injekcije
English: FIGURE 6
Croatian: SLIKA 6.
English: 7 Remove needle cap.
Croatian: Skinite kapicu igle.
English: Uncommon elevations in liver function tests (LFTs) for ALT (alanine aminotransferase) or AST (aspartate aminotransferase), have been observed in patients after receiving pegfilgrastim following cytotoxic chemotherapy.
Croatian: Manje često su u bolesnika, koji su nakon citotoksične kemoterapije primili pegfilgrastim, zabilježeni slučajevi povišenja vrijednosti testova jetrene funkcije za ALT (alanin aminotransferazu) ili AST (aspartat aminotransferazu).
English: FIGURE 4
Croatian: SLIKA 4.
English: It should be given at least 24 hours after your last dose of chemotherapy, at the end of each chemotherapy cycle.
Croatian: Uobičajena doza je jedna supkutana injekcija od 6 mg (injekcija pod kožu) primijenjena pomoću napunjene štrcaljke, koja se mora dati najmanje 24 sata nakon posljednje doze kemoterapije na kraju svakog kemoterapijskog ciklusa.
English: *The active substance is a covalent conjugate of filgrastim produced in Escherichia coli cells by recombinant DNA technology with polyethylene glycol (PEG).
Croatian: Koncentracija iznosi 10 mg/ml samo na temelju proteinskog dijela**. * Djelatna tvar je kovalentni konjugat filgrastima proizvedenog u stanicama Escherichia coli tehnologijom rekombinantne DNK s polietilenglikolom (PEG).
English: Injecting UDENYCA yourself
Croatian: Samostalno davanje lijeka UDENYCA
English: Before administration, pegfilgrastim solution should be inspected visually for particulate matter.
Croatian: 6.6 Posebne mjere za zbrinjavanje i druga rukovanja lijekom Prije primjene potrebno je provjeriti sadrži li otopina pegfilgrastima vidljive čestice.
English: • bleeding from the lung (pulmonary haemorrhage)
Croatian: • krvarenje iz pluća
English: 11 Dispose of syringe and treat injection site.
Croatian: 11. Odložite štrcaljku i zbrinite mjesto primjene injekcije.
English: • increased spleen size
Croatian: • povećanje slezene.
English: Pulmonary adverse reactions
Croatian: Plućne nuspojave
English: Monday Tuesday Wednesday Thursday Friday Saturday Sunday
Croatian: Ponedjaljak Utorak Srijeda Četvrtak Petak Subota.Nedjelja
English: It is particularly important that you tell your doctor if you are taking or have recently taken:
Croatian: Osobito je važno obavijestiti liječnika ako uzimate ili ste nedavno uzimali:
English: This leaflet was last revised in {MM/YYYY}.
Croatian: Ova uputa je posljednji puta revidirana u {MM/GGGG}
English: ND = Not Determined, ↑ = Increased, ↓ = Decreased, ↔ = No Effect
Croatian: NO = Nije određeno, ↑ = Povećano, ↓ = Smanjeno, ↔ = Bez učinka
English: If Nevirapine Teva has been prescribed for your child, please note that all information in this leaflet is addressed to your child (in this case please read “your child” instead of “you”).
Croatian: Ako je Nevirapin Teva propisan Vašem djetetu, imajte na umu da se svi podaci u ovoj uputi odnose na Vaše dijete (u ovom slučaju, molimo, čitajte “Vaše dijete” umjesto “Vi”)
English: Contains lactose: see leaflet for further information.
Croatian: Sadrži laktozu: vidjeti uputu za dodatne informacije.
English: Your doctor might need to monitor whether your other medicines are still working and adjust doses.
Croatian: Vaš liječnik će možda morati pratiti ima li Vaš drugi lijek još djelovanje i prilagoditi dozu.
English: - weigh 50 kg or more
Croatian: imaju 50 ili više kilograma
English: Gender and older people
Croatian: Spol i starije osobe
English: Therefore, you may continue to develop infections and other illnesses associated with HIV infection.
Croatian: Kod Vas se i dalje mogu javljati infekcije ili druge bolesti povezane s HIV infekcijom.
English: Date of first authorisation: 30 November 2009 Date of latest renewal: 26 August 2014
Croatian: Datum posljednje obnove: 26. kolovoz 2014.
English: Contact your doctor if you notice changes in body fat (see section 4 “Possible side effects”).
Croatian: Javite se liječniku ako primijetite promjene u tjelesnim masnoćama (vidjeti dio 4 “Moguće nuspojave”).
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/.
Croatian: Detaljnije informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove: http://www.ema.europa.eu
English: You should therefore remain in regular contact with your doctor.
Croatian: Stoga je važno da ostanete u kontaktu s Vašim liječnikom.
English: Nevirapine Teva tablets can be taken by: - children 16 years of age or older - children under 16 years of age who:
Croatian: Nevirapin Teva tablete mogu uzimati: - djeca od 16 i više godina starosti - djeca ispod 16 godina starosti koja:
English: This is especially important within the first 14 days of treatment (see more information in “How to take Nevirapine
Croatian: Ovo je osobito važno unutar prvih 14 dana liječenja (za više informacija vidjeti dio "Kako uzimati Nevirapin Teva“).
English: Your doctor might then decide to restart you on a lower dose.
Croatian: Vaš liječnik potom može odlučiti da Vam ponovno počne davati lijek ali u nižoj dozi.
English: White opaque PVC/PE/PVdC - Aluminium blisters or OPA/Alu/PVC - Aluminium blisters.
Croatian: Bijeli neprozirni PVC/PE/PVdC - aluminijski blisteri ili OPA/Alu/PVC - aluminijski blisteri.
English: - if you are allergic to nevirapine or any of the other ingredients of this medicine (listed in section
Croatian: - ako ste alergični na nevirapin ili bilo koji drugi sastojak ovog lijeka (naveden u dijelu 6)
English: 14 tablets 60 tablets 120 tablets
Croatian: 14 tableta 60 tableta 120 tableta
English: One side is debossed with "N", a scoreline and "200".
Croatian: Jedna strana ima utisnutu oznaku „N“, s razdjelnom crtom i oznakom „200“.
English: The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
Croatian: Razdjelna crta služi samo kako bi se olakšalo lomljenje radi lakšeg gutanja, a ne da bi se lijek podijelio na jednake doze.
English: Your doctor will carefully monitor the effect of Nevirapine Teva and any of these medicines if you are taking them together.
Croatian: Liječnik će pažljivo pratiti učinak Nevirapina Teva i svakog od ovih lijekova ako ih uzimate zajedno.
English: There are no specific studies about the ability to drive vehicles and use machinery.
Croatian: Ne postoje specifična ispitivanja o sposobnosti upravljanja vozilima i rada na strojevima.
English: Cartons containing 14 tablets (Calendar Pack).
Croatian: Kutije sa 14 tableta (kalendarsko pakovanje).
English: Monitoring of hepatic tests should be done every two weeks during the first 2 months of treatment, at the 3rd month and then regularly thereafter.
Croatian: Jetrene testove treba ponavljati svaka dva tjedna tijekom prva 2 mjeseca liječenja, u trećem mjesecu i zatim redovito nakon toga.
English: It is in general recommended that you do not breast-feed if you have HIV infection because it is possible that your baby can become infected with HIV through your breast milk.
Croatian: Općenito se preporučuje da ne dojite ako imate infekciju HIV-om jer postoji mogućnost da se Vaše dijete zarazi HIV-om preko Vašeg mlijeka.
English: What Nevirapine Teva is and what it is used for
Croatian: Što je Nevirapin Teva i za što se koristi
English: For this reason, and to reduce the risk of HIV transmission, barrier contraception (e.g., condoms) is recommended.
Croatian: Iz tog razloga i radi smanjenja rizika od prijenosa HIV-a, preporučuje se barijerna kontracepcija (npr. kondomi).
English: Your doctor will recommend the best medicines for you.
Croatian: Liječnik će Vam preporučiti lijekove koji Vam najviše odgovaraju.
English: Talk to your doctor or pharmacist before taking Nevirapine Teva During the first 18 weeks of treatment with Nevirapine Teva it is very important that you and your doctor watch out for signs of liver or skin reactions.
Croatian: Savjetujte se s liječnikom ili ljekarnikom prije uzimanja Nevirapina Teva Tijekom prvih 18 tjedana liječenja Nevirapinom Teva, vrlo je važno da Vi i Vaš liječnik pratite znakove reakcija na jetri i koži.
English: Like all medicines, this medicine can cause side effects, although not everybody gets them.
Croatian: Kao i svi lijekovi, i ovaj lijek može uzrokovati nuspojave, iako se neće javiti kod svakoga.
English: In this 48week study no unexpected safety findings were observed in either dosing group.
Croatian: U ovom 48- tjednom ispitivanju nisu opaženi neočekivani sigurnosni problemi.
English: Methadone Individual Patient Dosing
Croatian: Doziranje metadona za pojedinog bolesnika
English: Since neither body weight nor Body Mass Index (BMI) had influence on the clearance of nevirapine, the effect of gender cannot be explained by body size.
Croatian: S obzirom da ni tjelesna težina niti indeks tjelesne mase (BMI) nisu utjecali na klirens nevirapina, učinak spola ne može se objasniti veličinom tijela.
English: East Sussex, BN22 9AG United Kingdom
Croatian: East Sussex, BN22 9AG Velika Britanija